Siemens Healthineers stock gains as RBC keeps Buy rating

Siemens Healthineers stock (ISIN DE000SHL1006) closed at EUR 37.97 on Xetra on September 21, 2026, while RBC maintained a Buy rating and a EUR 45 price target on September 22, 2026. The target stands EUR 7.03, or 18.51 percent, above the closing price.

RBC keeps the EUR 45 target

According to Zonebourse on September 22, 2026, RBC analyst Natalia Webster kept the Buy recommendation and the EUR 45 price target. The same report shows an average target of EUR 45.52, which is EUR 7.55 above the September 21 close.

The market data in the report also put the stock at EUR 38.05 in estimated Tradegate trading on September 22, 2026, up 0.21 percent. The reference quote remains the Xetra closing price because Siemens Healthineers is a German issuer.

Buyback adds a measurable support

According to Tradegate BSX on September 22, 2026, Siemens Healthineers acquired 89,988 shares between September 14 and September 20, 2026, under its ongoing buyback program. Cumulative purchases from June 1 through September 20 reached 3,214,359 shares.

The buyback is a concrete counterweight to the operational issue identified in current coverage. Simply Wall St wrote on September 22, 2026 that execution in Diagnostics restructuring and margin repair remains an immediate swing factor after the liver-testing partnership.

Stock stays below the target

The valuation gap is visible in the numbers: the EUR 45 RBC target is 18.51 percent above the September 21 Xetra close, while the EUR 45.52 average target is 19.89 percent higher. That comparison makes execution in Diagnostics the key variable behind the analyst case, rather than the buyback alone.

EUR 37.97 Xetra close

Siemens Healthineers stock closed at EUR 37.97 on Xetra on September 21, 2026. The September 22, 2026 market reference is therefore the completed Xetra session named by the available quote data.

More news and analyses on Siemens Healthineers stock